OMNIAB, INC. Increase Decrease In Operating Lease Liability
OMNIAB, INC. (OABI) reported Increase Decrease In Operating Lease Liability of -$1.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-06
- OMNIAB, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$757.00K.
- OMNIAB, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$748.00K.
- OMNIAB, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$735.00K.
- OMNIAB, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$714.00K.
- OMNIAB, INC. increase decrease in operating lease liability for fiscal 2025 was -$2.83M.
- OMNIAB, INC. increase decrease in operating lease liability for fiscal 2024 was -$2.44M.
- OMNIAB, INC. increase decrease in operating lease liability for fiscal 2023 was -$563.00K, a 131.10% decline from fiscal 2022.
- OMNIAB, INC. increase decrease in operating lease liability for fiscal 2022 was $1.81M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$757.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.50M 10-Q · filed 2026-08-06 | -$2.24M derived: sum of 3 quarters · filed 2026-08-06 | -$2.95M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$748.00K 10-Q · filed 2026-05-07 | -$1.48M derived: sum of 2 quarters · filed 2026-05-07 | -$2.20M derived: sum of 3 quarters · filed 2026-05-07 | -$2.89M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$735.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$1.45M derived: sum of 2 quarters · filed 2026-03-04 | -$2.15M derived: sum of 3 quarters · filed 2026-08-06 | -$2.83M 10-K · filed 2026-03-04 |
| 2025-09-30 | -$714.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$1.41M derived: sum of 2 quarters · filed 2026-08-06 | -$2.10M 10-Q · filed 2025-11-04 | -$2.81M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$696.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.38M 10-Q · filed 2026-08-06 | -$2.10M derived: sum of 3 quarters · filed 2026-08-06 | -$2.59M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$685.00K 10-Q · filed 2026-05-07 | -$1.40M derived: sum of 2 quarters · filed 2026-05-07 | -$1.89M derived: sum of 3 quarters · filed 2026-05-07 | -$2.49M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$714.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$1.21M derived: sum of 2 quarters · filed 2026-03-04 | -$1.81M derived: sum of 3 quarters · filed 2026-03-04 | -$2.44M 10-K · filed 2026-03-04 |
| 2024-09-30 | -$493.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$1.09M derived: sum of 2 quarters · filed 2025-11-04 | -$1.72M 10-Q · filed 2025-11-04 | -$2.67M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$602.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$1.23M 10-Q · filed 2025-08-06 | -$2.17M derived: sum of 3 quarters · filed 2025-08-06 | -$2.51M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$627.00K 10-Q · filed 2025-05-08 | -$1.57M derived: sum of 2 quarters · filed 2025-05-08 | -$1.91M derived: sum of 3 quarters · filed 2025-05-08 | -$1.25M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$943.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$1.28M derived: sum of 2 quarters · filed 2025-03-18 | -$625.00K derived: sum of 3 quarters · filed 2025-03-18 | -$563.00K 10-K · filed 2025-03-18 |
| 2023-09-30 | -$341.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $318.00K derived: sum of 2 quarters · filed 2024-11-12 | $380.00K 10-Q · filed 2024-11-12 | $318.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $659.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $721.00K 10-Q · filed 2024-08-08 | $659.00K derived: sum of 3 quarters · filed 2024-08-08 | -$385.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $62.00K 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-05-09 | -$1.04M derived: sum of 3 quarters · filed 2024-05-09 | $469.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$1.11M derived: sum of 2 quarters · filed 2024-03-25 | $407.00K derived: sum of 3 quarters · filed 2024-03-25 | $1.81M 10-K · filed 2024-03-25 |
| 2022-09-30 | -$1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $469.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.87M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $2.92M 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $1.40M 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | -$3.25M 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |